These findings support the idea of leptin as a factor enhancing the production of proinflammatory factors in OA cartilage and as an agent contributing to the obesity-associated increased risk for osteoarthritis. The gene discussed is LEP; the disease is obesity due to melanocortin 4 receptor deficiency.